Program
test toothpaste
Also written as “Test toothpaste”.
Its studies are mostly in Dentin Sensitivity · Hypersensitivity, led by Colgate Palmolive.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Colgate Palmolive | 20 open or running | phase 3since Apr 14, 2025 | Apr 14, 2025 | none ahead |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Apr 14, 2025First studies: 2 phase 3 studiesFirst studyNCT06937697, NCT06956599
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 2 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT06956599Dentin Sensitivity · China | 3 | Completed | Aug 11, 2025 | 80 |
| NCT06937697Hypersensitivity · China | 3 | Completed | Dec 13, 2024 | 87 |
How it is read
Names in the registry
- “test toothpaste”, 1 entry
- “Test toothpaste”, 1 entry
Conditions, from the studies’ own filings
- Dentin Sensitivity, 1 study
- Hypersensitivity, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.